Amicus Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation
SA Transcripts
140.66K Followers
The following slide deck was published by Amicus Therapeutics, Inc. in conjunction with their 2020 Q1 earnings call.
123
This article was written by
140.66K Followers
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
Recommended For You
Comments (1)
t
tkarl
07 May 2020
Talk about flattening the curve. Looks like product revenue is hitting the ceiling. Other potential catalysts are a year off. And the main revenue source is vulnerable to a competitor, with the next gen therapy barely on the radar. Eventually this may be a good investment, but it seems like there is no rush.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!